Lan Kang

3.0k citations

72 papers · 2.2k indexed · h-index 22

Impact in

Molecular Biology top 5%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Renal and related cancers
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- PI3K/AKT/mTOR signaling in cancer
- RNA modifications and cancer
Cancer Research top 10%

Papers in ⓘ

Molecular Biology 48
- Pluripotent Stem Cells Research 15
- CRISPR and Genetic Engineering 11
- Epigenetics and DNA Methylation 9
- Renal and related cancers 8
- RNA modifications and cancer 6
Cancer Research 14
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 6

Co-authors: Shaorong Gao (17 shared papers)Patrick I. Borgen (3 shared papers)Zhaohui Kou (6 shared papers)Rachel B. Hazan (2 shared papers)Yu Zhang (2 shared papers)Brian P. Whooley (1 shared paper)Faina Bogomolniy (1 shared paper)Esther Rhei (1 shared paper)
Journals: Cell Death and Disease (3 papers)American Journal of Perinatology (3 papers)Free Radical Biology and Medicine (2 papers)Theranostics (2 papers)Biology of Reproduction (2 papers)
Partner nations: China United States Russia

In The Last Decade

Lan Kang

67 papers receiving 2.2k citations

Peers

Countries citing papers authored by Lan Kang

Since Specialization

Citations

This map shows the geographic impact of Lan Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Kang more than expected).

Fields of papers citing papers by Lan Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Kang. The network helps show where Lan Kang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lan Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lan Kang Line = papers co-authored together Lan Kang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos Cell stem cell ·Lan Kang, Jianle Wang, Yu Zhang, Zhaohui Kou, Shaorong Gao	2009	320
2	Replacement of Oct4 by Tet1 during iPSC Induction Reveals an Important Role of DNA Methylation and Hydroxymethylation in Reprogramming Cell stem cell ·Yawei Gao, Jiayu Chen, Ke Li, Tong Wu, Bo Huang, Wenqiang Liu, Xiaochen Kou, Yu Zhang, Hua Huang, Yonghua Jiang, Chao Yao, Xiaolei Liu, Zhiwei Lü, Zijian Xu, Lan Kang, Jun Chen, Hailin Wang, Tao Cai, Shaorong Gao	2013	276
3	Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. PubMed ·Esther Rhei, Lan Kang, Faina Bogomolniy, M.G. Federici, Patrick I. Borgen, Jeffrey M. Boyd	1997	219
4	N-Cadherin Promotes Adhesion Between Invasive Breast Cancer Cells and the Stroma Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication ·Rachel B. Hazan, Lan Kang, Brian P. Whooley, Patrick I. Borgen	1997	192
5	Vinculin Is Associated with the E-cadherin Adhesion Complex Journal of Biological Chemistry ·Rachel B. Hazan, Lan Kang, S.M. Roe, Patrick I. Borgen, David L. Rimm	1997	133
6	Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation Neuroscience ·Shaoxia Wang, H. Wang, Hong Guo, Lan Kang, Xiumei Gao, Limin Hu	2011	99
7	RCOR2 Is a Subunit of the LSD1 Complex That Regulates ESC Property and Substitutes for SOX2 in Reprogramming Somatic Cells to Pluripotency Stem Cells ·Peng Yang, Yixuan Wang, Jiayu Chen, Hong Li, Lan Kang, Yu Zhang, She Chen, Bing Zhu, Shaorong Gao	2011	76
8	Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling Theranostics ·Yuan Cao, Shuhai Lin, Yongbin Wang, Y. Eugene Chin, Lan Kang, Jun Mi	2017	62
9	Reprogramming of Trophoblast Stem Cells into Pluripotent Stem Cells by Oct4 Stem Cells ·Tong Wu, Haitao Wang, Jing He, Lan Kang, Yonghua Jiang, Jinchao Liu, Yu Zhang, Zhaohui Kou, Lijun Liu, Xuehong Zhang, Shaorong Gao	2011	57
10	The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status Cellular Physiology and Biochemistry ·Mengying Wang, Yayun Zhang, Taishu Wang, Jinrui Zhang, Zhu Zhou, Yan Sun, Shanshan Wang, Yulin Shi, Xuelin Luan, Yingqiu Zhang, Yifei Wang, Yang Wang, Zou Zhong-wen, Lan Kang, Han Liu	2017	50
11	An Elaborate Regulation of Mammalian Target of Rapamycin Activity Is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors Stem Cells and Development ·Jing He, Lan Kang, Tong Wu, Jiqin Zhang, Haitao Wang, Haibo Gao, Yu Zhang, Bo Huang, Wenqiang Liu, Zhaohui Kou, Hongbing Zhang, Shaorong Gao	2012	43
12	LncRNAAC132217.4, a KLF8-regulated long non-coding RNA, facilitates oral squamous cell carcinoma metastasis by upregulating IGF2 expression Cancer Letters ·Xiaojie Li, Changhong Ma, Li Zhang, Na Li, Xiaohong Zhang, Jianya He, Ruiping He, Miaomiao Shao, Junling Wang, Lan Kang, Chuanchun Han	2017	43
13	Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas Molecular Cancer ·Jingshu Wang, Kun Zou, Feng Xu, Miao Chen, Cong Li, Ranran Tang, Xuan Yang, Meihua Luo, Wangbing Chen, Huijuan Qiu, Ge Qin, Yixin Li, Changlin Zhang, Binyi Xiao, Lan Kang, Tiebang Kang, Wenlin Huang, Xinfa Yu, Xiaojun Wu, Wuguo Deng	2017	41
14	High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cells Cell Research ·Gang Chang, Shuai Gao, Xinfeng Hou, Zijian Xu, Yanfeng Liu, Lan Kang, Yu Tao, Wenqiang Liu, Bo Huang, Xiaochen Kou, Jiayu Chen, Lei An, Kai Miao, Keqian Di, Zhilong Wang, Kun Tan, Tao Cheng, Tao Cai, Shaorong Gao, Jianhui Tian	2013	41
15	Mice Cloned from Induced Pluripotent Stem Cells (iPSCs)1 Biology of Reproduction ·Zhaohui Kou, Lan Kang, Ye Yuan, Yu Tao, Yu Zhang, Tong Wu, Jing He, Jianle Wang, Liu Z, Shaorong Gao	2010	35
16	Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells Leukemia ·Yong-Jun Liu, Hui Cheng, Shaorong Gao, Xuemei Lu, Fuhong He, Linping Hu, Duen‐Ren Hou, Zhenhua Zou, Y Li, Han Zhang, Jing Xu, Lan Kang, Qi Wang, Weiping Yuan, S Gao, Tao Cheng	2013	33
17	CRISPR/Cas12a-Enhanced Loop-Mediated Isothermal Amplification for the Visual Detection of Shigella flexneri Frontiers in Bioengineering and Biotechnology ·Yaoqiang Shi, Lan Kang, Rongrong Mu, Min Xu, Xiaoqiong Duan, Yujia Li, Chunhui Yang, Jia-wei Ding, Qinghua Wang, Shilin Li	2022	32
18	KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway Cell Death and Disease ·Changlin Zhang, Song Chen, Tianze Liu, Ranran Tang, Miao Chen, Fan Gao, Binyi Xiao, Ge Qin, Fen Shi, Wenbin Li, Yixin Li, Xiaoyan Fu, Dingbo Shi, Xiangsheng Xiao, Lan Kang, Wenlin Huang, Xiaojun Wu, Bing Tang, Wuguo Deng	2017	28
19	LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure Experimental and Molecular Pathology ·Lei Lai, Yizhou Xu, Lan Kang, Jianmin Yang, Gangjie Zhu	2020	28
20	RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma Theranostics ·Tianze Liu, Wenbin Li, Wenjing Lü, Miao Chen, Meihua Luo, Changlin Zhang, Yixin Li, Ge Qin, Dingbo Shi, Binyi Xiao, Huijuan Qiu, Wendan Yu, Lan Kang, Tiebang Kang, Wenlin Huang, Xinfa Yu, Xiaojun Wu, Wuguo Deng	2017	25

About Lan Kang

Lan Kang is a scholar working on Molecular Biology, Cancer Research, Physiology, Pulmonary and Respiratory Medicine and Oncology, having authored 72 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (15 papers), CRISPR and Genetic Engineering (11 papers), Epigenetics and DNA Methylation (9 papers), Renal and related cancers (8 papers), Neonatal Respiratory Health Research (7 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Molecular Biology (1.8k citations), Cancer Research (286 citations), Aging (21 citations), Cell Biology (149 citations) and Oncology (243 citations). Lan Kang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Shaorong Gao, Patrick I. Borgen, Zhaohui Kou, Rachel B. Hazan, Yu Zhang, Brian P. Whooley, Faina Bogomolniy, Esther Rhei, Jeffrey M. Boyd and M.G. Federici. Their work appears in journals such as Cell Death and Disease, American Journal of Perinatology, Free Radical Biology and Medicine, Theranostics and Biology of Reproduction.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact